• Advicenne organizes a symposium on the latest clinical news and registry.
• Poster presentation on October 5th for additional data on ADV7103 in dRTA Patients.

Advicenne (Euronext: ADVIC), a specialist pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases, announces today that the company strengthens its scientific relationship with the European Society for Paediatric Nephrology (ESPN) during the 51st Annual Meeting which is being held October 3-8, 2018, in Antalya, Turkey. The relationship now accelerates with the active execution phase of the partnership announced on May 15th, 2018…